Alligator Announces First Patient Dosed in Phase II Clinical Trial with Shanghai Henlius Biotech, Inc. & AbClon, Inc.

Alligator Bioscience AB (“Alligator” or the “Company”) today announced that the Company was notified that the first patient has been dosed in its Phase II clinical trial collaboration with Shanghai …
( read original story …)

---